Tissue engineering for the treatment of short bowel syndrome in children

Laura Y. Martin, Mitchell R. Ladd, Adam Werts, Chhinder Sodhi, John C. March, David Hackam

Research output: Contribution to journalReview article

Abstract

Short bowel syndrome is a major cause of morbidity and mortality in children. Despite decades of experience in the management of short bowel syndrome, current therapy is primarily supportive. Definitive treatment often requires intestinal transplantation, which is associated with significant morbidity and mortality. In order to develop novel approaches to the treatment of short bowel syndrome, we and others have focused on the development of an artificial intestine, by placing intestinal stem cells on a bioscaffold that has an absorptive surface resembling native intestine, and taking advantage of neovascularization to develop a blood supply. This review will explore recent advances in biomaterials, vascularization, and progress toward development of a functional epithelium and mesenchymal niche, highlighting both success and ongoing challenges in the field.

Original languageEnglish (US)
Pages (from-to)249-257
Number of pages9
JournalPediatric Research
Volume83
Issue number1-2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Short Bowel Syndrome
Tissue Engineering
Intestines
Morbidity
Child Mortality
Biocompatible Materials
Stem Cells
Therapeutics
Epithelium
Transplantation
Mortality

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Tissue engineering for the treatment of short bowel syndrome in children. / Martin, Laura Y.; Ladd, Mitchell R.; Werts, Adam; Sodhi, Chhinder; March, John C.; Hackam, David.

In: Pediatric Research, Vol. 83, No. 1-2, 01.01.2018, p. 249-257.

Research output: Contribution to journalReview article

Martin, Laura Y. ; Ladd, Mitchell R. ; Werts, Adam ; Sodhi, Chhinder ; March, John C. ; Hackam, David. / Tissue engineering for the treatment of short bowel syndrome in children. In: Pediatric Research. 2018 ; Vol. 83, No. 1-2. pp. 249-257.
@article{e1bc98af051d40febdbe200ca1745642,
title = "Tissue engineering for the treatment of short bowel syndrome in children",
abstract = "Short bowel syndrome is a major cause of morbidity and mortality in children. Despite decades of experience in the management of short bowel syndrome, current therapy is primarily supportive. Definitive treatment often requires intestinal transplantation, which is associated with significant morbidity and mortality. In order to develop novel approaches to the treatment of short bowel syndrome, we and others have focused on the development of an artificial intestine, by placing intestinal stem cells on a bioscaffold that has an absorptive surface resembling native intestine, and taking advantage of neovascularization to develop a blood supply. This review will explore recent advances in biomaterials, vascularization, and progress toward development of a functional epithelium and mesenchymal niche, highlighting both success and ongoing challenges in the field.",
author = "Martin, {Laura Y.} and Ladd, {Mitchell R.} and Adam Werts and Chhinder Sodhi and March, {John C.} and David Hackam",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/pr.2017.234",
language = "English (US)",
volume = "83",
pages = "249--257",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1-2",

}

TY - JOUR

T1 - Tissue engineering for the treatment of short bowel syndrome in children

AU - Martin, Laura Y.

AU - Ladd, Mitchell R.

AU - Werts, Adam

AU - Sodhi, Chhinder

AU - March, John C.

AU - Hackam, David

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Short bowel syndrome is a major cause of morbidity and mortality in children. Despite decades of experience in the management of short bowel syndrome, current therapy is primarily supportive. Definitive treatment often requires intestinal transplantation, which is associated with significant morbidity and mortality. In order to develop novel approaches to the treatment of short bowel syndrome, we and others have focused on the development of an artificial intestine, by placing intestinal stem cells on a bioscaffold that has an absorptive surface resembling native intestine, and taking advantage of neovascularization to develop a blood supply. This review will explore recent advances in biomaterials, vascularization, and progress toward development of a functional epithelium and mesenchymal niche, highlighting both success and ongoing challenges in the field.

AB - Short bowel syndrome is a major cause of morbidity and mortality in children. Despite decades of experience in the management of short bowel syndrome, current therapy is primarily supportive. Definitive treatment often requires intestinal transplantation, which is associated with significant morbidity and mortality. In order to develop novel approaches to the treatment of short bowel syndrome, we and others have focused on the development of an artificial intestine, by placing intestinal stem cells on a bioscaffold that has an absorptive surface resembling native intestine, and taking advantage of neovascularization to develop a blood supply. This review will explore recent advances in biomaterials, vascularization, and progress toward development of a functional epithelium and mesenchymal niche, highlighting both success and ongoing challenges in the field.

UR - http://www.scopus.com/inward/record.url?scp=85044566914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044566914&partnerID=8YFLogxK

U2 - 10.1038/pr.2017.234

DO - 10.1038/pr.2017.234

M3 - Review article

C2 - 28937976

AN - SCOPUS:85044566914

VL - 83

SP - 249

EP - 257

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1-2

ER -